• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫球蛋白超家族成员在复杂生物网络中的免疫原性特性。

Immunogenic properties of immunoglobulin superfamily members within complex biological networks.

机构信息

Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70228, Ciudad Universitaria, México, DF 04510, Mexico.

Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70228, Ciudad Universitaria, México, DF 04510, Mexico.

出版信息

Cell Immunol. 2020 Dec;358:104235. doi: 10.1016/j.cellimm.2020.104235. Epub 2020 Oct 11.

DOI:10.1016/j.cellimm.2020.104235
PMID:33137645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7548077/
Abstract

Antibodies, T cell receptors and major histocompatibility complex molecules are members of the immunoglobulin superfamily and have pivotal roles in the immune system. The fine interrelation between them regulates several immune functions. Here, we describe lesser-known functions ascribed to these molecules in generating and maintaining immune response. Particularly, we outline the contribution of antibody- and T cell receptor-derived complementarity-determining region neoantigens, antigenized antibodies, as well as major histocompatibility complex class I molecules-derived epitopes to the induction of protective/therapeutic immune responses against pathogens and cancer. We discuss findings of our own and other studies describing protective mechanisms, based on immunogenic properties of immunoglobulin superfamily members, and evaluate the perspectives of application of this class of immunogens in molecular vaccines design.

摘要

抗体、T 细胞受体和主要组织相容性复合体分子是免疫球蛋白超家族的成员,在免疫系统中起着关键作用。它们之间的精细相互关系调节着几种免疫功能。在这里,我们描述了这些分子在产生和维持免疫反应方面的一些鲜为人知的功能。特别是,我们概述了抗体和 T 细胞受体衍生的互补决定区新抗原、抗原化抗体以及主要组织相容性复合体 I 类分子衍生的表位对诱导针对病原体和癌症的保护性/治疗性免疫反应的贡献。我们讨论了自己和其他研究的发现,这些研究描述了基于免疫球蛋白超家族成员免疫原性的保护性机制,并评估了这一类免疫原在分子疫苗设计中的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe9/7548077/1b3359b838ab/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe9/7548077/1b3359b838ab/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe9/7548077/1b3359b838ab/gr1_lrg.jpg

相似文献

1
Immunogenic properties of immunoglobulin superfamily members within complex biological networks.免疫球蛋白超家族成员在复杂生物网络中的免疫原性特性。
Cell Immunol. 2020 Dec;358:104235. doi: 10.1016/j.cellimm.2020.104235. Epub 2020 Oct 11.
2
Specificity for molecules of the major histocompatibility complex mediated by a hybrid immunoglobulin-T cell receptor.由杂交免疫球蛋白-T细胞受体介导的对主要组织相容性复合体分子的特异性。
New Biol. 1991 May;3(5):487-97.
3
T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma.多发性骨髓瘤中独特型单克隆IgG重链和轻链的T细胞表位图谱分析
Int J Cancer. 1999 Mar 1;80(5):671-80. doi: 10.1002/(sici)1097-0215(19990301)80:5<671::aid-ijc7>3.0.co;2-e.
4
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis.抗T细胞受体免疫反应的多样性及其对多发性硬化症T细胞疫苗治疗的意义。
Brain. 1998 Aug;121 ( Pt 8):1395-407. doi: 10.1093/brain/121.8.1395.
5
Germ line tumor-associated immunoglobulin VH region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells.生殖系肿瘤相关免疫球蛋白VH区肽引发肿瘤特异性免疫反应,而不改变正常B细胞的反应潜能。
Blood. 2004 Aug 1;104(3):752-9. doi: 10.1182/blood-2004-01-0105. Epub 2004 Mar 30.
6
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma.多发性骨髓瘤中肿瘤衍生免疫球蛋白重链的互补决定区和构架区内的T细胞表位
Blood. 2003 Jun 15;101(12):4930-6. doi: 10.1182/blood-2002-04-1250. Epub 2003 Feb 6.
7
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.T细胞受体样抗体:临床癌症免疫学和免疫疗法的新型试剂。
Expert Rev Anticancer Ther. 2005 Jun;5(3):523-36. doi: 10.1586/14737140.5.3.523.
8
The molecules of the immune system.免疫系统的分子
Sci Am. 1985 Oct;253(4):122-31. doi: 10.1038/scientificamerican1085-122.
9
Diversity in the immune system: "preconceived ideas" or ideas preconceived?免疫系统中的多样性:“先入为主的观念”还是“预先形成的观念”?
Biochimie. 1985 Jan;67(1):9-27. doi: 10.1016/s0300-9084(85)80226-1.
10
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies.构建嵌合的人源和鼠源主要组织相容性复合体(MHC)I类四聚体以生产T细胞受体(TCR)模拟抗体。
PLoS One. 2017 Apr 27;12(4):e0176642. doi: 10.1371/journal.pone.0176642. eCollection 2017.

引用本文的文献

1
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy.T淋巴细胞中调节性免疫受体的可变剪接:一种新发现的且可靶向的抗癌免疫治疗机制。
Front Immunol. 2025 Jan 7;15:1490035. doi: 10.3389/fimmu.2024.1490035. eCollection 2024.
2
T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis.特应性皮炎中的 T 细胞共刺激和共抑制途径。
Front Immunol. 2023 Mar 13;14:1081999. doi: 10.3389/fimmu.2023.1081999. eCollection 2023.

本文引用的文献

1
Humoral autoimmunity after solid organ transplantation: Germinal ideas may not be natural.实体器官移植后的体液性自身免疫:生发中心的想法可能并不自然。
Cell Immunol. 2020 Aug;354:104131. doi: 10.1016/j.cellimm.2020.104131. Epub 2020 May 19.
2
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.SARS-CoV-2 疫情意大年夜利中间爆发严重川崎病样病:一项不雅察性队列研究。
Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
3
Immune-related adverse events of checkpoint inhibitors.
检查点抑制剂的免疫相关不良反应。
Nat Rev Dis Primers. 2020 May 7;6(1):38. doi: 10.1038/s41572-020-0160-6.
4
Germline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire.胚系编码的 TCR-MHC 接触促进脐带血 T 细胞受体库中 TCR V 基因偏倚。
Front Immunol. 2019 Aug 30;10:2064. doi: 10.3389/fimmu.2019.02064. eCollection 2019.
5
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients.单一 T 细胞表位驱动多发性硬化症患者对那他珠单抗的中和性抗药物抗体反应。
Nat Med. 2019 Sep;25(9):1402-1407. doi: 10.1038/s41591-019-0568-2. Epub 2019 Sep 9.
6
The inhibitory receptor CD94/NKG2A on CD8 tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.CD8 肿瘤浸润淋巴细胞上的抑制性受体 CD94/NKG2A 在结直肠癌中的作用:在 HLAE/β2m 过表达背景下有前途的新的可药物治疗的免疫检查点。
Mod Pathol. 2020 Mar;33(3):468-482. doi: 10.1038/s41379-019-0322-9. Epub 2019 Aug 13.
7
The Promise of Anti-idiotype Revisited.抗独特型抗体的前景展望。
Front Immunol. 2019 Apr 12;10:808. doi: 10.3389/fimmu.2019.00808. eCollection 2019.
8
Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study.免疫检查点抑制剂(程序性死亡-1抑制剂和细胞毒性T淋巴细胞相关蛋白-4抑制剂)的不良反应:一项回顾性研究的结果
J Clin Med Res. 2019 Apr;11(4):225-236. doi: 10.14740/jocmr3750. Epub 2019 Mar 18.
9
Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection.移植中的待解决问题:B 细胞、同种抗体和体液排斥。
Am J Transplant. 2019 Aug;19(8):2155-2163. doi: 10.1111/ajt.15323. Epub 2019 Apr 10.
10
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.人自然杀伤细胞:表面受体、抑制性检查点及转化应用。
Cell Mol Immunol. 2019 May;16(5):430-441. doi: 10.1038/s41423-019-0206-4. Epub 2019 Feb 18.